Logo image of SUM

Summit Materials Inc (SUM) Stock Fundamental Analysis

NYSE:SUM - New York Stock Exchange, Inc. - US86614U1007 - Common Stock - Currency: USD

52.49  +0.04 (+0.08%)

After market: 52.55 +0.06 (+0.11%)

Fundamental Rating

4

We assign a fundamental rating of 4 out of 10 to SUM. SUM was compared to 12 industry peers in the Construction Materials industry. SUM has only an average score on both its financial health and profitability. SUM is valued quite expensive, but it does show an excellent growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

4

1. Profitability

1.1 Basic Checks

SUM had positive earnings in the past year.
In the past year SUM had a positive cash flow from operations.
Each year in the past 5 years SUM has been profitable.
SUM had a positive operating cash flow in each of the past 5 years.
SUM Yearly Net Income VS EBIT VS OCF VS FCFSUM Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 100M 200M 300M 400M

1.2 Ratios

SUM has a Return On Assets of 1.75%. This is amonst the worse of the industry: SUM underperforms 91.67% of its industry peers.
With a Return On Equity value of 3.31%, SUM is not doing good in the industry: 91.67% of the companies in the same industry are doing better.
SUM has a Return On Invested Capital of 4.51%. This is amonst the worse of the industry: SUM underperforms 91.67% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for SUM is significantly below the industry average of 10.60%.
Industry RankSector Rank
ROA 1.75%
ROE 3.31%
ROIC 4.51%
ROA(3y)5.18%
ROA(5y)4.04%
ROE(3y)11.46%
ROE(5y)9.43%
ROIC(3y)4.89%
ROIC(5y)4.65%
SUM Yearly ROA, ROE, ROICSUM Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2 4 6 8 10

1.3 Margins

SUM's Profit Margin of 3.92% is on the low side compared to the rest of the industry. SUM is outperformed by 83.33% of its industry peers.
In the last couple of years the Profit Margin of SUM has grown nicely.
SUM's Operating Margin of 12.64% is on the low side compared to the rest of the industry. SUM is outperformed by 66.67% of its industry peers.
SUM's Operating Margin has improved in the last couple of years.
The Gross Margin of SUM (29.81%) is comparable to the rest of the industry.
In the last couple of years the Gross Margin of SUM has remained more or less at the same level.
Industry RankSector Rank
OM 12.64%
PM (TTM) 3.92%
GM 29.81%
OM growth 3Y10.44%
OM growth 5Y8.05%
PM growth 3Y22.64%
PM growth 5Y46.57%
GM growth 3Y2.73%
GM growth 5Y-0.58%
SUM Yearly Profit, Operating, Gross MarginsSUM Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 10 20 30

More info and screens

4

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), SUM is destroying value.
The number of shares outstanding for SUM has been increased compared to 1 year ago.
Compared to 5 years ago, SUM has more shares outstanding
SUM has a worse debt/assets ratio than last year.
SUM Yearly Shares OutstandingSUM Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 20M 40M 60M 80M 100M
SUM Yearly Total Debt VS Total AssetsSUM Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 1B 2B 3B 4B 5B

2.2 Solvency

An Altman-Z score of 2.36 indicates that SUM is not a great score, but indicates only limited risk for bankruptcy at the moment.
SUM has a Altman-Z score of 2.36. This is comparable to the rest of the industry: SUM outperforms 41.67% of its industry peers.
The Debt to FCF ratio of SUM is 16.66, which is on the high side as it means it would take SUM, 16.66 years of fcf income to pay off all of its debts.
SUM has a worse Debt to FCF ratio (16.66) than 75.00% of its industry peers.
A Debt/Equity ratio of 0.63 indicates that SUM is somewhat dependend on debt financing.
SUM's Debt to Equity ratio of 0.63 is on the low side compared to the rest of the industry. SUM is outperformed by 83.33% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.63
Debt/FCF 16.66
Altman-Z 2.36
ROIC/WACC0.51
WACC8.78%
SUM Yearly LT Debt VS Equity VS FCFSUM Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 500M 1B 1.5B 2B

2.3 Liquidity

A Current Ratio of 3.10 indicates that SUM has no problem at all paying its short term obligations.
SUM has a Current ratio of 3.10. This is amongst the best in the industry. SUM outperforms 91.67% of its industry peers.
SUM has a Quick Ratio of 2.48. This indicates that SUM is financially healthy and has no problem in meeting its short term obligations.
With an excellent Quick ratio value of 2.48, SUM belongs to the best of the industry, outperforming 91.67% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 3.1
Quick Ratio 2.48
SUM Yearly Current Assets VS Current LiabilitesSUM Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 500M 1B 1.5B

More info and screens

8

3. Growth

3.1 Past

The Earnings Per Share has been growing slightly by 1.27% over the past year.
SUM shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 59.94% yearly.
SUM shows a strong growth in Revenue. In the last year, the Revenue has grown by 49.48%.
Measured over the past years, SUM shows a small growth in Revenue. The Revenue has been growing by 4.51% on average per year.
EPS 1Y (TTM)1.27%
EPS 3Y24.17%
EPS 5Y59.94%
EPS Q2Q%-7.41%
Revenue 1Y (TTM)49.48%
Revenue growth 3Y3.94%
Revenue growth 5Y4.51%
Sales Q2Q%47.35%

3.2 Future

The Earnings Per Share is expected to grow by 25.33% on average over the next years. This is a very strong growth
Based on estimates for the next years, SUM will show a very strong growth in Revenue. The Revenue will grow by 24.77% on average per year.
EPS Next Y10.65%
EPS Next 2Y22.95%
EPS Next 3Y25.33%
EPS Next 5YN/A
Revenue Next Year64.9%
Revenue Next 2Y33.36%
Revenue Next 3Y24.77%
Revenue Next 5YN/A

3.3 Evolution

The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
SUM Yearly Revenue VS EstimatesSUM Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 1B 2B 3B 4B
SUM Yearly EPS VS EstimatesSUM Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 1 2 3

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 32.81, SUM can be considered very expensive at the moment.
Compared to the rest of the industry, the Price/Earnings ratio of SUM indicates a slightly more expensive valuation: SUM is more expensive than 75.00% of the companies listed in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 26.30, SUM is valued a bit more expensive.
SUM is valuated rather expensively with a Price/Forward Earnings ratio of 22.12.
SUM's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. SUM is cheaper than 66.67% of the companies in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 22.06. SUM is around the same levels.
Industry RankSector Rank
PE 32.81
Fwd PE 22.12
SUM Price Earnings VS Forward Price EarningsSUM Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

SUM's Enterprise Value to EBITDA ratio is in line with the industry average.
Based on the Price/Free Cash Flow ratio, SUM is valued a bit more expensive than the industry average as 66.67% of the companies are valued more cheaply.
Industry RankSector Rank
P/FCF 54.44
EV/EBITDA 13.43
SUM Per share dataSUM EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15 20 25

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates SUM does not grow enough to justify the current Price/Earnings ratio.
A more expensive valuation may be justified as SUM's earnings are expected to grow with 25.33% in the coming years.
PEG (NY)3.08
PEG (5Y)0.55
EPS Next 2Y22.95%
EPS Next 3Y25.33%

More info and screens

0

5. Dividend

5.1 Amount

SUM does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

Summit Materials Inc

NYSE:SUM (2/10/2025, 8:24:42 PM)

After market: 52.55 +0.06 (+0.11%)

52.49

+0.04 (+0.08%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryConstruction Materials
Earnings (Last)02-13 2025-02-13/amc
Earnings (Next)04-29 2025-04-29/amc
Inst Owners65.2%
Inst Owner Change-92.77%
Ins OwnersN/A
Ins Owner Change-1.08%
Market Cap9.23B
Analysts70.53
Price Target50.1 (-4.55%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)6.89%
Min EPS beat(2)6.65%
Max EPS beat(2)7.13%
EPS beat(4)4
Avg EPS beat(4)19.52%
Min EPS beat(4)6.65%
Max EPS beat(4)48.07%
EPS beat(8)8
Avg EPS beat(8)18.03%
EPS beat(12)10
Avg EPS beat(12)12.07%
EPS beat(16)13
Avg EPS beat(16)13.68%
Revenue beat(2)0
Avg Revenue beat(2)-4.78%
Min Revenue beat(2)-5.63%
Max Revenue beat(2)-3.93%
Revenue beat(4)1
Avg Revenue beat(4)-0.73%
Min Revenue beat(4)-5.63%
Max Revenue beat(4)11.01%
Revenue beat(8)4
Avg Revenue beat(8)-0.21%
Revenue beat(12)6
Avg Revenue beat(12)0.01%
Revenue beat(16)9
Avg Revenue beat(16)2.46%
PT rev (1m)-6.66%
PT rev (3m)-7.35%
EPS NQ rev (1m)1.5%
EPS NQ rev (3m)1.5%
EPS NY rev (1m)1.99%
EPS NY rev (3m)1.99%
Revenue NQ rev (1m)-0.85%
Revenue NQ rev (3m)-0.75%
Revenue NY rev (1m)-0.14%
Revenue NY rev (3m)0.02%
Valuation
Industry RankSector Rank
PE 32.81
Fwd PE 22.12
P/S 2.46
P/FCF 54.44
P/OCF 17.11
P/B 2.08
P/tB 4.16
EV/EBITDA 13.43
EPS(TTM)1.6
EY3.05%
EPS(NY)2.37
Fwd EY4.52%
FCF(TTM)0.96
FCFY1.84%
OCF(TTM)3.07
OCFY5.85%
SpS21.36
BVpS25.29
TBVpS12.63
PEG (NY)3.08
PEG (5Y)0.55
Profitability
Industry RankSector Rank
ROA 1.75%
ROE 3.31%
ROCE 6.03%
ROIC 4.51%
ROICexc 4.98%
ROICexgc 7.24%
OM 12.64%
PM (TTM) 3.92%
GM 29.81%
FCFM 4.51%
ROA(3y)5.18%
ROA(5y)4.04%
ROE(3y)11.46%
ROE(5y)9.43%
ROIC(3y)4.89%
ROIC(5y)4.65%
ROICexc(3y)5.44%
ROICexc(5y)5.16%
ROICexgc(3y)8.1%
ROICexgc(5y)7.79%
ROCE(3y)6.53%
ROCE(5y)6.21%
ROICexcg growth 3Y3.53%
ROICexcg growth 5Y5.58%
ROICexc growth 3Y6.61%
ROICexc growth 5Y7.42%
OM growth 3Y10.44%
OM growth 5Y8.05%
PM growth 3Y22.64%
PM growth 5Y46.57%
GM growth 3Y2.73%
GM growth 5Y-0.58%
F-Score6
Asset Turnover0.45
Health
Industry RankSector Rank
Debt/Equity 0.63
Debt/FCF 16.66
Debt/EBITDA 3.33
Cap/Depr 100.52%
Cap/Sales 9.85%
Interest Coverage 3.17
Cash Conversion 64.03%
Profit Quality 115.02%
Current Ratio 3.1
Quick Ratio 2.48
Altman-Z 2.36
F-Score6
WACC8.78%
ROIC/WACC0.51
Cap/Depr(3y)109.47%
Cap/Depr(5y)97.16%
Cap/Sales(3y)9.87%
Cap/Sales(5y)9.04%
Profit Quality(3y)56.33%
Profit Quality(5y)121.42%
High Growth Momentum
Growth
EPS 1Y (TTM)1.27%
EPS 3Y24.17%
EPS 5Y59.94%
EPS Q2Q%-7.41%
EPS Next Y10.65%
EPS Next 2Y22.95%
EPS Next 3Y25.33%
EPS Next 5YN/A
Revenue 1Y (TTM)49.48%
Revenue growth 3Y3.94%
Revenue growth 5Y4.51%
Sales Q2Q%47.35%
Revenue Next Year64.9%
Revenue Next 2Y33.36%
Revenue Next 3Y24.77%
Revenue Next 5YN/A
EBIT growth 1Y50.79%
EBIT growth 3Y14.79%
EBIT growth 5Y12.92%
EBIT Next Year197.56%
EBIT Next 3Y54.11%
EBIT Next 5YN/A
FCF growth 1Y203.77%
FCF growth 3Y-7.52%
FCF growth 5YN/A
OCF growth 1Y88.16%
OCF growth 3Y2.38%
OCF growth 5Y15.95%